EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of Anticancer Effects of Aloe vera on 3D Liver Tumor Spheroids in a Microfluidic Platform

Atakan Tevlek iD, Gunes Kibar, Barbaros Cetin

Biotechnology and Bioengineering · 2025

DOI: 10.1002/bit.29033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2025. Verfasst von Atakan Tevlek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Atilim University, Ankara, Turkey. Hauptthemen laut MEDLINE: Aloe, Spheroids, Cellular, Antineoplastic Agents, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The study was supported by the Türkiye Bilimsel ve Teknolojik Arastirma Kurumu..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The search for effective anticancer therapies has increasingly focused on natural compounds like Aloe vera , renowned for its therapeutic properties. This study investigates the anticancer properties of Aloe vera on 3D liver tumor spheroids via a PDMS‐based microfluidic device, providing a more physiologically realistic model compared to traditional 2D cultures. HepG2 cells were cultivated to generate 3D spheroids on‐chip, thereafter subjected to different concentrations of Aloe vera and the chemotherapeutic drug Doxorubicin to evaluate cytotoxic effects. The microfluidic system, validated by COMSOL simulations, facilitated continuous perfusion and real‐time assessment of cell viability over a duration of 10 days. The results indicated that Aloe vera markedly diminished cell viability by triggering apoptosis at concentrations over 12.5 mg/mL. IC50 values were determined at 72 h: 25 ± 0.10 mg/mL for Aloe vera and 5.47 ± 0.03 µg/mL for Doxorubicin in 2D cultures, but in 3D cultures, the IC50 values were 31.25 ± 0.14 mg/mL for Aloe vera and 8.33 ± 0.05 µg/mL for Doxorubicin. This study underscores the promise of Aloe vera as a natural anticancer agent and illustrates the efficacy of microfluidic platforms for enhanced drug screening and customized medicine applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AloeSpheroids, CellularAntineoplastic AgentsLiver NeoplasmsPlant ExtractsHumansHep G2 CellsCell SurvivalDoxorubicinLab-On-A-Chip DevicesApoptosis

Stichwörter der Autor:innen

3D cell cultureAloe veraanticancer agentmicrofluidic

Substanzen

Antineoplastic AgentsDoxorubicinPlant Extracts

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Medicine, Atilim University, Ankara, Turkey.
  • Department of Materials Science and Engineering, Micro Nano Particles (MNP) Research Group, Adana Alparslan Turkes Science and Technology University, Adana, Turkey.
  • UNAM - Institute of Materials Science and Nanotechnology, Bilkent University, Ankara, Turkey.
  • Department of Mechanical Engineering, Microfluidics & Lab-on-a-chip Research Group, Bilkent University, Ankara, Turkey.

ORCID-Profile: Atakan Tevlek

Förderung

  • The study was supported by the Türkiye Bilimsel ve Teknolojik Arastirma Kurumu.

Zitieren

APA

Tevlek, A., Kibar, G., & Cetin, B. (2025). Assessment of Anticancer Effects of Aloe vera on 3D Liver Tumor Spheroids in a Microfluidic Platform. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.29033

Vancouver

Tevlek A, Kibar G, Cetin B. Assessment of Anticancer Effects of Aloe vera on 3D Liver Tumor Spheroids in a Microfluidic Platform. Biotechnology and Bioengineering. 2025. doi:10.1002/bit.29033

BibTeX
@article{Tevlek2025,
  author = {Tevlek, Atakan and Kibar, Gunes and Cetin, Barbaros},
  title = {Assessment of Anticancer Effects of Aloe vera on 3D Liver Tumor Spheroids in a Microfluidic Platform},
  journal = {Biotechnology and Bioengineering},
  year = {2025},
  doi = {10.1002/bit.29033}
}
Kostenlos starten →